Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On April 19, 2022, the Company’s Board of Directors approved a management reorganization pursuant to which Nitya G. Ray, Ph.D., will continue in his role as Chief Technology Officer, but will no longer serve as Chief Operating Officer. Also, Christopher P. Recknor, M.D., will serve as Senior Director of Research and Development, but will no longer be an executive officer of the Company as defined in the rules of the Securities and Exchange Commission.


https://ir.stockpr.com/cytodyn/sec-filings-em...269d8k.htm